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Abstract           
 
Background: For Diffusion Tensor Imaging (DTI) to become a clinically useful tool 
in the detection of traumatic brain injury (TBI) and prediction of functional 
outcome, a reliable method enabling the identification of likely injury in 
individual patients needs to be developed. 
 
Objective: To explore different methods of analysing DTI measures to determine 
if individual TBI patients can be differentiated from a group of non-brain injured 
controls and if so, how these differences are associated with cognitive function. 
 
Method: 4 participants with TBI and 11 control participants were scanned using 
DTI and completed a battery of neuropsychological tests. The DTI measures of 
Fractional Anisotropy (FA) and Mean Diffusivity (MD) in the uncinate fasciculus 
were compared across individual TBI patients and a control group using 3 
different methods of analysis.  
 
Results: The comparison of mean FA/MD from individual TBI patients with the 
overall mean FA/MD of the control group revealed that some TBI patients had 
lower values of FA whilst others had increased MD. This difference in FA may be 
associated with deficits in measures of attention.  The histogram curves and 
cumulative frequency plots for individual TBI patients and the controls revealed 
subtle yet potentially significant differences in the distribution of FA/MD. 
However at this stage these differences could not be associated with cognitive 
function. 
 
 
Conclusion: Initial findings indicate that individual TBI patients can be 
differentiated from a control group using different methods with differing 
degrees of sensitivity. These differences may be related to cognitive function 
but further research is warranted before firm conclusions can be drawn.  
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Introduction                                                                                                                                                                       
 
Traumatic brain injury (TBI) is a leading cause of disability worldwide [1]. In 
England the average yearly rate of reported TBI is 229 per 100,000 people [2]. 
The detection of TBI and determination of its severity is crucial to the accurate 
prediction of a patient’s functional outcome and enables the most appropriate 
and timely intervention to be made.   
 
TBI results from external mechanical or biomechanical forces that are great 
enough to permanently or temporarily impair  neuronal function [3]. In severe 
cases of TBI, the forces involved result in the stretching of axons, which causes 
damage to the neurofilaments and microtubules running throughout them and 
often results in cell death. Cell death however is rare in milder forms of TBI (mTBI) 
and any damage caused to axons is thought to be largely reversible [4].  
 
The classification of TBI severity is in part determined by an individual’s Glasgow 
Coma Scale (GCS) at the time of first medical assessment. Additional scales 
such as length of time of unconsciousness and duration of post traumatic 
amnesia (PTA) are also used to improve classification of TBI severity [5], however 
whilst these assessment measures are helpful in the acute stages of a TBI, they 
are not accurate predictors of functional outcome i.e. cognitive ability, 
following TBI [4], [6], [7], [8],[9].  
 
Brain imaging methods are therefore also employed to provide further 
information about the extent of injury. Computerised Tomography (CT) can 
differentiate between ‘complicated’ mild TBI defined by the presence of visible 
brain injury and ‘uncomplicated’ mTBI, which results in a scan lacking signs of 
pathology.   However this differentiation also has poor predictive value for 
functional outcome [9]. Unlike CT, Magnetic Resonance Imaging (MRI) can 
detect focal structural lesions and is 25-30% more sensitive in identifying Diffuse 
Axonal Injury (DAI) [10], a key feature of 40-50% of the TBIs that require hospital 
treatment [11]. However, Schrader et al. [12] note that MRI scans of 1.0 Telsa (T) 
taken immediately or 3 months post injury are rarely, if at all, able to detect 
axonal injury resulting from ordinary concussion. Again there is poor correlation 
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between MRI and neuropsychological measures [13] or functional outcome 
[14].  
 
The difficulties with predicting functional outcome are particularly prevalent in 
mTBI. In the vast majority of mTBIs, symptoms such as cognitive dysfunction, 
headache and dizziness have resolved within weeks of injury [15] and individuals 
do not develop any long-standing impairment. However Lannsjö et al. [16] 
revealed a significant number of people continue to experience related 
symptoms 3 months after their injury. Often in these cases CT and MRI scans are 
negative i.e. they do not show any areas of identifiable brain injury. In the 
absence of clear physiological explanation for the continued experience of 
symptoms, several psychological and social factors have been proposed to 
contribute to the persistence of symptoms including involvement in litigation [17] 
[18], the ‘Good-Old-Days’ bias [19] and a misinterpretation of symptoms [20]. 
 
However, with the development of Diffusion Tensor Imaging (DTI), an 
application of MRI which unlike traditional brain imaging methods permits the 
visualization of white matter tracts and therefore areas of probable diffuse 
axonal injury, the possibility has been raised that areas of brain damage 
resulting from TBI may be present but are as yet undetected by conventional 
methods.  This has led to DTI being posited as a non-invasive tool in the 
improved detection of brain injury [21].  
 
DTI utilises the principle of anisotrophy; in white matter water diffuses at a 
significantly faster rate along an axon rather than across it [22]. Commonly used 
measures derived from DTI include Fractional Anisotropy (FA), a scalar value 
between 0-1, which represents the directionality of the anisotropic water 
diffusion (1 is equal to fully anisotropic diffusion).  FA is thought to represent the 
integrity of the axonal membrane and myelin sheath [23]. Mean Diffusivity (MD) 
is another commonly used DTI measure, which represents the average amount 
of water diffusion in a given region and is thought to be influenced by the 
integrity and size of the axon [24].  
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Various methods have been used in patient-control group studies looking for 
changes to white matter that can be revealed by the comparison of DTI 
measures between groups.  Cercignani [25] describes 4 methods commonly 
used: a simple region of interest comparison between patient and control 
brains, whole brain histogram analysis which is considered useful where diffuse 
changes are likely to occur, the co-registration of patient and control brain into 
a standardised space and tractography, and the reconstruction of selected 
white matter pathways of interest.  
 
Significantly the use of these methods has enabled the identification of 
changes in the diffusion of water which relate to potential underlying damage, 
in brain regions that appear normal on standard T2 scans in the acute [26][27] 
and chronic stages [28] of TBI. These stages are thought have a differential 
effect on FA values; in the acute phase of injury when inflammation and 
oedema are key features, FA is generally considered to increase, while the 
chronic stage of TBI is associated with decreased FA likely representing 
underlying degeneration and cell death [29] but see [30][31]. 
 
A number of studies that have compared groups of patients with TBIs of varying 
severity and a control group, have identified differences in DTI measures in a 
range of brain regions (see table 1 for summary). 
   
To determine whether observed changes in DTI measures have a functional 
relevance, their relationship with cognitive function has also been explored. 
Kraus et al. [32] demonstrated that at 6 months post TBI, the number of areas of 
white matter damage was associated with increased severity and negatively 
correlated with performance across measures of attention, memory and 
executive function.   
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  Table 1.  Summary of white matter regions DTI studies have identified as  
  significantly different from controls in patients with TBIs of varying severities 
 
 
Mild TBI Moderate-Severe TBI 
Anterior corona radiate [33] Cingulum [32] 
Cingulum [33] [34] External capsule [32] 
Cortico-spinal tract [32] Forceps major/minor [32] [36] 
Dorsolateral Prefrontal cortex 
[30] 
Inferior fronto-occipital 
Fasciculus [32] 
Corpus callosum [31][33][35] Sagital striatum [32] 
 
Inferior longitudinal fasciculus 
[33] 
Perforant pathway [36] [37] 
Sagital striatum [32] Corpus callosum [32] [38] 
Superior longitudinal 
Fasciculus [32] 
Arcuate Fasciculus [38] 
Uncinate Fasciculus [33] Cortico-spinal tract [32] 
Internal capsule [35] Superior longitudinal 
Fasciculus [38] 
 Fornix [38] 
 Corona radiata [32] [36]  
 Hippocampus [37] 
 Thalamus [36] 
 Superior Longitudinal 
Fasciculus [32] 
 
   
  
  
At 1 month following mTBI injury, Niogi [33] reported that the number of white 
matter lesions detected by DTI, but not the number of microhaemorrhages 
detected by 3T MRI, was correlated with mean reaction time on the Attention 
Network Task in people with post-concussion syndrome symptoms, thus 
suggesting that DTI is a better predictor of cognitive impairment in mTBI than 
measures obtained from MRI. 
 
 Several studies have specifically investigated groups of people who 
sustained mTBI and have cognitive impairment (as determined by 
neuropsychological assessment) several months following their injury, although it 
is unclear as to the specific nature of the impairment. Lo et al. [38] reported that 
patients with mTBI and persistent cognitive impairment had decreased FA in the 
genu of corpus callosum. Lipton et al. [30] also identified reduced FA in the 
corpus callosum but furthermore in subcortical white matter and bilateral 
internal capsules.  
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More specially, increased FA in the midbrain has been shown to relate to 
reduced executive function test performance 3 weeks following mild-moderate 
TBI and is able to differentiate a group of symptomatic patients i.e. those 
reporting symptoms relating to TBI, from an asymptomatic control group 6 
months after injury [39].  In addition, decreased FA in the thalamic projection 
fibres is correlated with reduced performance on a number of executive 
functioning tasks in the chronic stages of recovery (12months+) following mild-
moderate TBI [36] and areas of reduced FA in the dorsolateral prefrontal cortex 
2 weeks after mTBI, have been shown to be significantly correlated with poor 
performance on executive function [30].  
 
The evidence base for DTI as a valuable technique in identifying regions of likely 
white matter damage in groups of TBI patients is developing rapidly. However, 
to use DTI techniques as a clinical tool in the prediction of functional outcome 
for TBI patients, a reliable method that enables an individual with TBI to be 
differentiated from a non-brain-injured control group, needs to be established. 
 
Singh et al. [40] recently described a novel technique enabling the 
identification of regions of white matter damage in individuals.   By comparing 
normalised FA in regions of interest of individuals with mild-moderate injury and 
a control group, they describe changes in the hippocampus/fornix, inferior 
fronto-occipital fasciculus, inferior longitudinal fasciculus, corpus callosum (genu 
and splenium), cortico-spinal tracts and the uncinate fasciculus of the patients 
at 1 month following TBI. However it is unclear whether the observed changes 
correspond to any functional outcome in terms of performance on cognitive 
measures. 
 
Lipton et al. [41] compared individual mTBI paitents with cognitive impairment 
but negative MRI scans, to a control group by using whole brain histogram 
analysis.  They identified decreased FA in the corpus callosum and internal 
capsule in the individual TBI patients. Consequently the authors concluded that 
their findings provided evidence that DTI could be used as a clinical tool for the 
assessment of individuals. However it is unclear which aspects of cognitive 
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function were impaired in the mTBI patients and how any impairments were 
related to the observed change in FA. Furthermore, whole brain voxelwise 
analysis has been critised for rarely taking into account the substantial effects 
that regions that are not of interest but are difficult to exclude from the analysis 
(such as the cerebral spinal fluid), have on the measures obtained [42].  
 
The aims of the present study were therefore to establish a method that enables 
an individual who has sustained a TBI to be differentiated from a non brain-
injured control group based on measures obtained from DTI, and, to determine 
how these measures may be related to cognitive function following a TBI.  Three 
methods of analysing individual TBI patient measures with a control group were 
explored; one which compared the means of DTI measures from a region of 
interest and two which analysed distributions of raw DTI measures between 
individuals and controls. 
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Methods                                                                                         ...  
 
Participants 
Participants formed 2 groups. The TBI patient group consisted of 4 participants (1 
female, 3 male, age range 25-65 years) who had sustained a traumatic brain 
injury 12-24 months prior to invitation to participate in the study and were 
current or recent outpatients at a local community brain injury rehabilitation 
unit.  The control group consisted of 11 right-handed participants (5 male, 6 
female; age range 25-43 years). Control participants were recruited from a 
control database at Cardiff University Brain Imaging Centre.  Participants who 
had been scanned using DTI in the preceding 3 years were considered eligible 
to participate.  Demographic and clinical characteristics where applicable are 
found in Figure 1.  
 
All eligible participants were screened to exclude those with previous or current 
significant mental heath problems, neurological problems, alcohol or substance 
abuse and physical impairment (see Appendix M for full exclusion/inclusion 
criteria). All control participants also confirmed no previous significant head 
injury. Two control participants did report a likely past concussion. 
 
The study was approved by NHS ethics and the Research and Development 
committee of the local NHS trust. The School of Psychology ethics committee at 
the Universities of Cardiff and Exeter also approved the study.  All participants 
were deemed to have capacity to consent to participate and provided written 
consent to participate in the research. 
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 Table 2.  Clinical and demographic characteristics of Participants (exact ages  
 of TBI patients have not been provided for reasons of anonymity) 
 
  Gender  Age Range  TBI Patient/Control  Injury 
Severity 
1  F  25‐30  TBI Patient  Mod‐Severe 
2  M  50‐54  TBI Patient  Mod‐Severe 
3  M  60‐65  TBI Patient  Mod‐Severe 
4  M  30‐34  TBI Patient  Mod‐Severe 
5  F  31  Control  ‐ 
6  F  36  Control  ‐ 
7  F  25  Control  ‐ 
8  M  31  Control  ‐ 
9  F  32  Control  ‐ 
10  F  35  Control  ‐ 
11  M  43  Control  ‐ 
12  M  37  Control  ‐ 
13  M  38  Control  ‐ 
14  M  38  Control  ‐ 
15  F  37  Control  ‐ 
 
      
 
Neuropsychological Assessment 
Participants who sustained a TBI were administered a range of 
neuropsychological tests as part of their routine care. The tests were selected by 
the Clinical Neuropsychologist involved in their assessment for clinical reasons 
prior to their involvement in the study. Tests that were completed by the majority 
of the TBI patient participants were included in the analysis. The 
neuropsychological tests selected for control participants were therefore based 
on this opportunistic sample and aimed to form a standardised battery covering 
key aspects of cognition comparable to those tested in patients. Time restraints 
and administrative error meant that some neuropsychological test data is 
missing for control participants.  All tests are well established and commonly 
used in clinical neuropsychology settings. The core domains of verbal and visual 
memory, attention, executive function and processing speed were assessed. 
Executive Function is a complex All raw scores were converted to standardised 
scores before analysis. 
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• Verbal Memory  
 Immediate and Delayed Verbal Memory was assessed using the 
 Californian Verbal Learning Test  (CVLT-II; [43].    
 
• Visual Memory 
 Immediate and Delayed Visual Memory ability was assessed by the 
 Family Pictures and Visual Reproduction subtests of the Wechsler Memory 
 Scale III (WMS-III; [44].  
 
• Processing Speed 
 The Digit-Symbol-Coding and Symbol Search subtests of the WAIS-II  [45] 
 and Trail making Test A were used to measure  processing speed.  
 
• Attention 
 The Continuous Performance Test – 2 (CPT-2; [46] was used  to assess 
 attention.   
 
• Executive Function 
 Executive functioning is a complex concept of cognition which includes 
 cognitive flexibility, planning, inhibition and rule acquisition.  A range of 
 tests would be necessary to fully characterise this domain.  However for 
 this study, the Trails B subtest was used to determine cognitive flexibility 
 but it is also sensitive to processing speed [47]. 
 
Table 3. Summary of the neuropsychological tests completed by each participant 
 
Neuropsychological 
test 
1 2 3 4 
 
5 6 7 8 9 10 11 12 13 14 15 
CPT-2 * *  * * * * * * * * * * * * 
WAIS-III – Symbol 
Search 
* * * * * * * * * * * * * * * 
WAIS-III – Digit 
Symbol Coding 
* * * * * * * * * * * * * * * 
CVLT-2 * * * * * * * * * * * * * * * 
WMS-III – Family 
Pictures 
* * *  * * * * * * * * * * * 
WMS-III – Visual 
Reproduction 
* * * * * * * * * * * * * * * 
Trails A and B * * * * * * * * * * * * *  * 
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2.3 DTI Acquisition and analysis  
 
Diffusion weighted MR data were acquired on a 3.0 Tesla HDx system (General 
Electric), using an 8 channel head coil.  The pulse sequence was a twice-
refocused spin-echo echoplanar imaging EPI sequence [48], acquired with 
data acquisition matrix = 96 × 96; field of view = 230 × 230 mm; in-plane 
resolution = 2.4 × 2.4 mm, parallel imaging factor = 2. Diffusion encoding 
gradients were applied in 30 non-collinear directions, isotropically distributed 
[49] with a b-value of 1200 s/mm2. 6 MR images without diffusion weighting were 
also acquired.  
 
2.4 DTI Processing 
 
The DTI data were analysed and processed in Explore DTI [50].  Data were 
corrected for subject motion and eddy-current induced geometric distortions 
[51]. Using non-linear regression, a single diffusion tensor was applied to the raw 
diffusion data in each voxel.  The diffusion data were then used to produce 
fractional anisotropy and mean diffusivity maps.  
 
For whole brain tractography, DTI data were first co-registered to standarised 
anatomical space (Montreal NeuroIogical Institute space). The uncinate 
fasciculus (UF) was chosen as the white matter tract of interest based on the 
finding of an in-house preliminary study, confidence in the accuracy of 
reconstruction and previous research evidence that has implicated the tract in 
TBI [33].  The UF was extracted using a validated in-house method based on the 
selection of 3 regions of interest (areas which were known to contain the matter 
tracts of the UF and eliminate fibres belonging to other tracts).  A deterministic 
streamline method was used to visualise the white matter tract. 
 
2.5 Analysis of DTI measures and Neuropsychological Testing 
 
 Where mean values of FA and MD of individual TBI patients were 
calculated and compared to the mean FA and MD of all control participants 
95% confidence intervals (CI; equal to +/- 1.96 standard deviations) of the 
control mean were calculated. TBI patient values falling outside the 95% CI were 
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considered to be statistically significant. Histograms of the raw FA and MD data 
for each region of interest (ROI) were also plotted and overlaid using Matlab (v. 
7.3.0) with overall control mean and 95% CI calculated. 
 
For neuropsychological testing, all raw scores were converted into age-adjusted 
standardized scores.  Using a case series approach similar to that used by Tonks 
et al. [52], the control participants’ standardised scores were averaged.  Scores 
from TBI patients which fell outside of the 95% CI of the control mean (+/- 1.96 
standard deviations from the mean) were considered significantly different from 
controls.  
 
To compare DTI measures with neuropsychological tests, mean FA/MD values 
for each participant were plotted against the age-adjusted standardised score 
in the test of interest and a Pearson’s r correlation coefficient for the 2 variables 
was calculated.  Only measures that appeared to be associated were 
compared in this way.  
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Results                                                                               
 
To develop a reliable method that enables the discrimination of individual TBI 
patients from a non-brain-injured control group, 3 different methods were 
explored to determine which may offer the greatest sensitivity in detecting 
differences in FA and MD in the UF. 
 
Method 1:  Mean Plot Analysis 
 
The mean FA/MD of each individual participant was plotted against the mean 
FA/MD of each participant forming the control group.  The average of the 
control FA/MD mean and the 95% confidence interval were calculated and 
represented on the mean plot graph.    
 
In both the left and right UF, the mean FA of TBI patients 1 and 4 is lower than 
the control group average FA and fell outside of the 95% CI (Figure 1A and 
figure 1B) indicating that there is likely to be a significant difference in the FA 
values for these TBI patients compared to the control group.  This difference 
may represent a decrease in the integrity of the left and right UF and underlying 
DAI resulting from their TBI. The mean FA for the left and right UF of TBI patients 2 
and 3 however (Figure 1A and 1B), were located within the 95% CI of the control 
group’s overall mean FA indicating that the left and right UF of these TBI patients 
appears to be no different from that of controls and may have been 
undamaged in their TBI.   
 
Mean plots of individual and control average MD of the right and left UF were 
also produced and the control group average and 95% CI represented.  A 
different pattern to that obtained for FA values in the UF can be observed for 
the measure of MD.  TBI patients 3 and 4 have mean MD values higher than the 
95% CI of the control mean MD in both the left and right UF (Figure 1C and 1D). 
Increased MD is another potential indicator of a loss of integrity to the white 
matter tract likely to result from TBI.  Despite increased FA, TBI patient 1 together 
with TBI patient 2, had average MD values that fell within the 95% CI of the 
control group mean for both the left and right UF (Figure 1C and 1D). 
  18 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  Table 4. Summary of significant findings for DTI measures using Method 1:  
  Mean plot analysis (marked by ‘*’) from right and left UF for T
 
 
 FA MD Total 
Patient L UF R UF L UF R UF  
1 * ↓ * ↓   2 
2     0 
3   * ↑ * ↑ 2 
4 *↓ * ↓ * ↑ * ↑ 4 
 
 
  
 
 
 
Method 2: Individual Histogram Analysis 
 
It is possible that the averaging of FA/MD raw values to calculate mean values 
for each participant as used in method 1, can obscure any subtle differences 
that may exist in the data.   For example, a person with normally distributed FA 
that peaked at a value of 0.5 would have the same average value as a person 
whose FA was non-normally distributed and peaked twice at values of 0.25 and 
0.75.  Therefore, the averaging of values may occlude any difference in the 
distribution of FA that may represent changes in the integrity of the tracts being 
measured.  To overcome this potential problem, histograms of the frequency of 
raw FA/MD values in the UF were produced for each TBI patient and control 
participant and overlaid (Figure 2).  As for the mean plot method, the control 
average histogram curve was calculated together with the 95% CI, and 
represented on the histogram.   
 
The histogram curves for the FA in the left UF supports observations from the 
mean plot analysis and reveals that the majority of points of the control 
participant curves fall within the 95% CI range of the control group mean FA 
curve (figure 2A). FA values in the control group peak at around 0.4. However, 
  20 
  21 
the histogram curve for TBI patient 4 appears significantly shifted towards lower 
FA values with the highest frequency of values at 0.1-0.2.  The frequencies of 
many other FA values also fall outside of the 95% CI curve.  A similar, although 
less extreme pattern is observed for TBI patient 1; the highest frequency of FA 
values is positioned between 0.3-0.4 with the frequency of lower FA values 
being greater than in control participants and falling outside the 95% CI (figure 
2A).  
 
Interestingly, in addition to these observations, there are several points where 
the histogram curve for TBI patients 3 and 4 can also be seen to fall outside of 
the control 95% CI (figure 2A). TBI patient 3 has fewer FA values of 0.5-0.6 than 
the control group controls whilst TBI patient 2 has a greater frequency of FA 
values than the control group at this point (figure 2A).   
 
A similar pattern can be observed for FA values in the right UF (figure 2B).  
Consistent with findings from the mean plot analysis, the histogram curves for TBI 
patients 1 and 4 fall outside of the 95% CI for the overall mean FA of control 
participants and in both instances are skewed towards a greater frequency of 
lower FA values (Figure 2B).  However the histogram curve for TBI patient 3 can 
also be seen to shift towards a greater frequency of lower FA values than the 
control group. Again it is important to note that some control participants’ FA 
values also fall outside of the 95% CI for controls in this region of interest. 
 
Histograms of the distribution of MD frequencies in the UF of TBI patients and 
control participants were also produced. The histogram curves of both the left 
and right UF reveal that TBI patients 3 and 4 have a notably greater frequency 
of higher MD values than control participants but a reduced frequency of lower 
MD values when compared to controls (figure 2C and 2D).  There is also a subtle 
shift in the distribution of TBI patient 1 towards a higher frequency of higher MD 
values in both the left and right UF. Interestingly in the left UF, TBI patient 2 has, 
unlike other TBI patients, a higher frequency of lower MD values than the control 
group (figure 2C).   
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The histogram analysis therefore appears to replicate the significant differences 
between TBI patients and control group participant that were revealed in the 
mean plot analysis, but also reveals that the distribution of FA and MD in the TBI 
patients that were indistinguishable from the control group by mean plot 
analysis, is subtly different from that of controls and may represent altered 
integrity of the UF that was previously unidentified in the mean plot analysis of 
method 1. However, it is also important to note that the histogram curves for 
control participants can occasionally also be seen to deviate by a small 
amount from the 95% CI for controls (Figure 2A, 2B and 2C). Interestingly in the 
left UF (Figure 2A) one of the participants who fell outside of the 95% CI was a 
control participant who reported previous concussion. However, they showed a 
slight increase in FA at values 0.55-0.65, similar to that of TBI patient 2. As 
increased FA values are generally thought to be associated with a greater 
integrity of white matter tracts, it is unclear whether the same mechanism may 
underlie the increased FA for the control and patient participant. Control 
participants without concussion also fall outside the 95% CI so it is not possible to 
draw any conclusion about the significance of the observation at this stage. 
 
  Table 4. Summary of significant findings using Method 2: Histogram analysis  
  (marked by ‘*’) for right and left UF for TBI. ↑ represents an increase in FA/MD  
  value from mean, ↓ represents a decrease in FA/MD value from mean 
 
 
 
 FA MD Total 
Patient L UF R UF L UF R UF  
1 * ↓  * ↓  * ↑  * ↑  4 
2 * ↑   * ↓   2 
3 * ↓  * ↓  * ↑  * ↑  4 
4 * ↓  * ↓  * ↑  * ↑  4 
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Method 3: Cumulative Frequency Plot 
 
An alternative way of representing the distribution of FA and MD values is in the 
form of a cumulative frequency graph.  This is a useful method that enables a 
visual representation of whether values fall outside those of a normally 
distributed group. 
 
Using this method of analysis, TBI patients 1, 3 and in particular, TBI patient 4, are 
again shown to have a greater proportion of lower FA values than the control 
group in the left and right UF (Figure 3A and 3B). Interestingly in the left UF, the 
cumulative curve for TBI patient 2 can be seen to deviate from the control 
mean curve in the opposite direction to other TBI patients; the patient has fewer 
low FA values than the control group until approximately a value of 0.45 when 
the curve becomes more consistent with that the control mean curve (Figure 
3A).  This is the first time that TBI patient 2 appears to deviate from the control 
mean and suggests that cumulative frequency plot analysis may be more 
sensitive to differentiating TBI patients from controls than the mean plot or 
histogram analysis.  
 
Cumulative frequency curves for the MD in the left and right UF indicate a 
similar change in MD distribution as revealed by histogram analysis; TBI patients 
3 and 4 have fewer low MD values and a larger proportion of high MD values 
when compared to controls (figure 3C and 3D), this is particularly evident in the 
left UF (figure 3C).   
 
However, it is important to note that there are also control cumulative curves 
that also deviate notably from the mean. Given the very large number of data 
points involved, a Kolmogorov-Smirnov test to determine statistical significance 
of these differences was not considered appropriate. With very large sample 
sizes such as those used, very small deviations from the control would likely 
produce a significant result [53].  Therefore a significant limitation of this method 
is that it is not possible to determine if the differences in cumulative curve for TBI 
patients, or indeed control participants. 
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Despite this limitation, at this stage visual inspection of the cumulative frequency 
plots reveals subtle and large differences in the distribution of FA and MD in the 
UF of TBI patients when compared to controls that are generally consistent with 
findings from the histogram method of analysis.  The exception occurs in the 
right UF of TBI patient 2 where FA values appear to be greater, a previously 
unobserved finding.  
 
Functional significance of DTI Measures 
 
The neuropsychological tests completed by control and TBI patient participants 
were broadly categorized into 5 domains of cognitive function: attention, 
processing speed, visual memory, verbal memory and executive function.  Age-
adjusted standarised scores were calculated for all neuropsychological tests 
completed by control participants.  None of the scores obtained by the control 
participants were considered to be clinically significant.  
 
The age-adjusted standardized scores from the control participants were then 
averaged and the 95% CI of the scores calculated. The age-adjusted 
standardised scores for each neuropsychological test completed by the TBI 
patients were obtained from their medical records and compared to the 
control group average in a case series approach previously demonstrated by 
Tonks et al. [52].  TBI patient neuropsychological test scores that fell outside of 
the control 95% CI, were considered to be significantly different from the 
controls. All TBI patients had at least 1 neuropsychological test score that fell 
below the 95% CI of the control group.  When TBI patients had at least 1 
neuropsychological test score which fell below the 95% CI of the controls, this 
was considered to reflect an impairment in the cognitive domain that the 
neuropsychological test assessed.  All TBI patients therefore had at least 1 
cognitive domain with impaired functioning (see Table 4). For clinical reasons, 
TBI neuropsychological tests results of TBI patients are not available for all 
cognitive domains assessed in controls.  
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  Table 5. Summary of the cognitive domains shown to be impaired in TBI patients  
  when comparing their standardised score to the 95% CI of the control group.  
  * denotes areas of impairment 
 
 
TBI 
Patient 
Attention Processing 
Speed 
Visual 
Memory 
Verbal 
Memory 
Executive 
Function 
Total 
impaired 
cognitive 
domains 
1 *    * 2/5 (40%) 
2  * * *  3/5 (60%) 
3 n/a * * *  3/4 (75%) 
4 * * n/a *  3/4 (75%) 
 
  
 
To determine if the DTI measures obtained for the UF had any functional 
significance, the pattern of cognitive impairment found in the TBI patients seen 
in table 5 was compared to the DTI measures that were significantly different in 
TBI patients (table 3) when using the average FA/MD values calculated in 
method 1.  The tables reveal that TBI patients 1 and 4 have significantly lower FA 
values in the left and right UF and are also impaired in the cognitive domain of 
attention. TBI patient 2 however does not deviate from the control group in 
measures of attention or mean FA in the UF. Unfortunately neuropsychological 
scores for TBI patient 3 were not available for the domain of attention to 
determine if an association similar to that for TBI patients 1 and 4 could also be 
observed.  
 
To explore if there may be a relationship between scores on attention tests and 
average FA in the left and right UF, the standardised scores from all participants 
(TBI patients and controls) were correlated with the mean FA of either the left or 
right UF.  However at this stage it was not possible to identify a significant 
correlation between the 2 measures. 
 
With the existing data, the pattern of neuropsychological test results does not 
correspond to the pattern of average MD found in the UF i.e. TBI patient 3 and 4 
have increased MD compared to controls but they do not exclusively show 
impairment in any cognitive domain when other TBI patients are unimpaired. It is 
important to highlight that without a complete neuropsychological test dataset, 
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it is not possible to draw any firm conclusions about the significance, or lack of, 
these findings. 
 
The pattern of cognitive impairments for each participant (Table 5) was also 
compared to the pattern of results obtained from the histogram (Table 4).   With 
an increasing number of identified significant differences in DTI measures in the 
UF using these methods, it was not possible to observe a clear relationship 
between significant DTI measures and areas of cognitive impairment. Again, this 
does not mean that a relationship does not exist, simply that at this stage it has 
not been possible to identify one. 
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Discussion                                                                                        ... 
 
The present study investigated the potential for 3 different methods of analysis 
to enable the differentiation of individual TBI patients from a control group using 
measures obtained from DTI.   
 
It was possible to identify likely significant differences in the FA and MD 
measured in the Uncinate Fasciculus by comparing the mean of these values 
from the individual TBI patients with the control group mean.  It was observed 
that for some TBI participants FA values decreased in the UF whilst for others MD 
values increased compared to the control group.  These changes in FA/MD 
may indicate the compromised integrity of the white matter tracts of the UF that 
may have occurred as a result of TBI in these patients. 
 
Apparently subtler differences in FA/MD that may exist between individual TBI 
patients and a control group were however revealed by using a different 
method of analysis. By displaying the frequencies of FA/MD values found in the 
UF in the form of histograms and cumulative frequency plots, it was possible to 
identify differences in their distribution that were occluded by averaging the 
values.   Using these methods TBI patients who were not distinguishable from the 
control group when comparing mean FA/MD, were shown to have a distribution 
of FA/MD that was significantly different from controls. The cumulative 
frequency method was able to identify slightly more areas of likely differences in 
TBI patients compared to controls but as it was not possible to calculate if these 
differences were significant, it may be that the histogram method is most 
reliable.  As previously, a logical interpretation of the differences in FA/MD is that 
they represent the presence of underlying white matter damage that is likely to 
have occurred in the TBI patients.   
 
Although some previous studies have begun to investigate whether DTI 
measures from individual TBI patients with cognitive impairment can be 
differentiated from controls [41], it has yet to be determined how any of the 
observed changes may specifically relate to functional outcome. The present 
study sought to address this gap and has provided preliminary evidence to 
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suggest that there may be a relationship between DTI measures and cognitive 
function in the chronic stages of TBI when the mean plot analysis method was 
used. Although it was not possible to determine relationships between the 
neuropsychological test scores and the DTI measures for all the TBI patients, 
some interesting associations were observed. Impaired performance in tasks 
requiring attention may be related to reduced FA in the right and left UF in TBI 
patients.  The UF is not well understood but is thought to be part of the limbic 
system and has recently been implicated in the retrieval of famous face names 
[54] and auditory-verbal memory ability [55]. 
 
These findings are significant because for DTI to be a useful clinical tool in the 
detection of TBI and for it to contribute to the improved prediction of functional 
outcome, a method is required that enables the reliable identification of diffuse 
axonal injury in individual patients that can be related to an outcome measure 
such as cognitive ability.  The present study goes some way to providing a 
method that may enable the identification of areas of likely change to the 
integrity of white matter thought to represent DAI and cognitive outcome. 
 
It is interesting to note that where significant differences were identified in the 
FA/MD of the UF in individuals with TBI, measures in the both the right and left UF 
were found to be significantly different from controls.  This is particularly relevant 
given that information obtained from the non-diffusion weighted MRI scans 
usually suggests that for the majority of TBI, damage to one hemisphere is 
dominant.  Thus the finding that analysis of the DTI measures indicates bilateral 
damage to the UF, suggests that the methods of analysis used may reveal 
otherwise undetected areas of damage and more accurately reflect the 
diffuse nature of TBI. 
 
It is also the case however that clear evidence of significant brain damage can 
be seen on some of the TBI patients’ non-diffusion weighted scans yet analysis 
of the DTI measures does not always represent this damage, i.e. using these 
methods the TBI patients appear no different from controls. It may be that by 
only selecting the UF as a region of interest, brain regions with greater damage, 
which may be more predictive of outcome, have been missed. A number of 
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other questions are also raised by the present findings such as whether a 
reorganization/regeneration of neuronal pathways in these areas may have 
occurred and results in only subtle changes in FA/MD in the chronic stages 
following TBI.  The effects of premorbid characteristics such as education level 
and the age at which the TBI occurred are additional factors that may 
influence this effect. 
 
Previous research findings comparing groups of people who sustained a TBI with 
a group of controls often observed decreased FA and increased MD in the 
same region.  In the present study, the mean plot analysis method did not 
reveal this reciprocity in individual patients. However with the exception of the 
right UF in TBI patient 2, the histogram and cumulative frequency methods of 
analyses demonstrated it in all areas where significant differences between 
individual TBI patients and controls were found. It is questioned whether this 
supports the histogram and cumulative frequency plots as more sensitive 
measures of changes in FA/MD values. 
 
There are however several limitations of the present study. The small number of 
participants and the incomplete neuropsychological test data prevents 
statistically significant conclusions to be drawn. A clear improvement in the 
study design would be to increase the number of TBI patient participants to 
enable the methods to be further tested for reliability in differentiating TBI 
patients from a control group. It would also be beneficial to include a wide 
range of TBI injury severities to explore potential relationships between TBI 
severity and the degree of change to FA/MD values in the UF and indeed in 
other brain regions of interest. An increased sample size would also permit the 
possibility of exploring the possible effects that age may have on the DTI 
measures and any potential differences there may be in the recovery process 
following TBI.  Furthermore, the control group may also be unrepresentative of 
the general population, as the vast majority had scored above average in 
many domains in the neuropsychological tests.  It is therefore a possibility that 
the observed differences in FA/MD in TBI patients are confounded by 
differences in pre-morbid intellectual ability rather than a result of the TBI.  
Furthermore the TBI patient participants were not matched in age to the control 
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group. It is known that FA values are thought to decrease with age [56]. With an 
older age range, some of the differences in the DTI measures of TBI patient 
participants could be attributable to effects of age rather than brain injury per 
se. By increasing the size of the control population to include a wider range of 
demographic backgrounds a more representative and reliable control group 
would be achieved.  
  
A further limitation of the current design is that for both TBI patient and control 
participants, the time between neuropsychological testing and DTI scans 
acquisition varied considerably and in some instances was up to 2 years. As 
discussed DTI measures are known to be influenced by age so although 
observable, significant white matter changes attributed to aging would not be 
expected to occur over this time, it is not possible to rule out the possibility.  
Therefore future studies should seek to minimize the time between 
neuropsychological testing and brain imaging.  
 
It is also important to note that one of the TBI patients has a preexisting medical 
condition that may in some instances affect the nervous system. To our current 
knowledge, there is no evidence that this is the case, however it remains 
possible that the medical condition may have resulted in or contributed to the 
observed differences in DTI measures indentified in this patient. In future studies 
participants should be screened for such medical conditions to exclude the 
possibility of any confounding variables. 
 
A further limitation of the present study is the absence of conventional 
neuroimaging scans e.g. CT and MRI, for the TBI patient participants.   This 
additional source of information would help to provide further evidence of the 
site of brain injury and also help to determine if the DTI analysis methods 
developed are able to identify areas of potential damage that were not 
otherwise visible by conventional scans. 
 
Although commonly used in this field of research, deterministic tractograpy, the 
method of white matter tract visualisation employed in the present study, also 
has inherent limitations. The method becomes particularly problematic in 
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regions of crossing fibres [57], as the estimation of the direction of predominant 
diffusion and therefore the trajectory of the reconstructed pathway, will not 
necessarily follow the direction of the white matter tracts of interest [58] or may 
terminate erroneously [59]. Crucially it is not possible to know if errors have been 
made in the reconstruction of white matter tracts to be analysed [56] as the 
visual representation may appear to correspond to the tract of interest but it 
may also contain fibres from other tracts or may exclude fibres that do belong 
to it. Therefore additional tract visualisation methods such as Constrained 
Spherical Deconvolution should be used in additional studies to overcome this 
problem.  The present study has also not taken into account Partial Volume 
Effects (the effects of the surrounding grey matter on the analysis of a white 
matter tract), which are known to influence DTI measures, therefore a future 
study should consider their effects on any findings. 
 
To maximize the potential impact of developing the present study further, With a 
greater number of TBI patient participants it would also be interesting to explore 
the effect of demographic factors such as age and pre-morbid ability on DTI 
measures following TBI.  
  
It is important to note however that the predictive validity of DTI is still uncertain.  
Although previous studies have shown relationships between DTI measures and 
cognitive performance, there is currently still insufficient data from group or 
individual studies, to indicate what effect any difference in DTI measures in any 
given white matter tract would have on functional outcome. Indeed the link 
with observable brain pathology and functional outcome is still poorly 
understood. For example, evidence from autopsy studies have indicated that 
up to 30% of brains have signs of Alzheimer’s disease at autopsy but the 
symptoms of the disease were not present whilst the person was alive [60].  
Furthermore in the case of TBI, it has been discussed that the traditional brain 
imaging measures of CT and MRI are shown to be poorly related to functional 
outcome.  It may be that these methods are not as sensitive to certain types of 
pathology as DTI but it must also be considered that other factors may be 
involved in the level of functional outcome a person is able to achieve following 
a brain injury.  
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Functional outcome is not only determined by performance on 
neuropsychological tests and can include whether a person is able to return to 
work or reintegrate in their community. This in turn is thought to be influenced by 
many additional psychological and social factors such involvement and in 
litigation and beliefs about an illness.   
 
To maximize the potential impact of developing the present study further, 
additional variables that may influence the potential relationship between DTI 
measures and cognitive function and consequently help determine the 
predicative validity of DTI, should therefore be included.  For example 
depression and post-traumatic stress disorder are relatively common conditions 
following a TBI and have both been shown to be associated with reductions in 
FA [61][62]. Participant should be screened for these conditions and it may also 
be beneficial to include scales of assessing health beliefs (e.g. the Illness 
Perceptions Questionnaire-Revised [63].  Additional functional outcome 
measures such as an individual’s return to work status and quality of life should 
also be included. With a greater number of TBI patient participants it would also 
be interesting to explore the effect of demographic factors such as age and 
pre-morbid ability on DTI measures following TBI.  
 
Despite the limitations outlined above, the present study provides preliminary 
evidence that the use of DTI can enable the differentiation of individual TBI 
patients from controls by enabling the identification of regions of white matter 
that are likely to be damaged following TBI. To our knowledge this is the first 
study that has explored these methods of comparing the DTI measures of 
FA/MD obtained from a region of interest in individual TBI patients with those of 
a control group whilst seeking to establish how the observed changes in FA/MD 
may be related to specific cognitive functions.  
 
   
  34 
 
  35 
References                                                                                      
 
[1] Cassidy JD, Carroll LJ, Peloso PM, et al. Incidence, risk factors and 
 prevention of mild traumatic brain injury: results of the WHO 
 Collaborating Centre Task Force on Mild Traumatic Injury. Journal of 
 Rehabilitation Medicine 2004; 43(suppl):28-60  
 
 [2] Tennant, A. Admission to hospital following head injury in England: 
 incidence and socio-economic associations. 2005 BMC Public Health, 
 5, 21 
 
 
[3] Vasterling JJ, Verfaellie M, Sullivan KD. (2009) Mild traumatic brain injury 
 and posttraumatic stress disorder in returning veterans: 
 perspectives from cognitive neuroscience. Clin Psychol Review 
 2009;29(8):674-84. 
 
[4] McCrea M. Mild Traumatic Brain Injury and Postconcussion Syndrome: 
 The New Evidence Base for Diagnosis and Treatment (American 
 Academy of Clinical Neuropsychology Workshop Series). New York: 
 Oxford University Press, 2007 
 
[5] Stein, S.C, Classification of head injury.  In. Narayan RK, Povlishock JT, 
 WIlberger JE Jr, eds. Neurotrauma. New York: McGraw-Hill 1996, 31-42 
 
[6] Zafonte RD, Hammond FM, Mann NR, et al. (1996) Relationship 
 Between Glasgow Coma Scale and Functional Outcome. Am J Phys 
 Med  Rehab 1996;75(5): 364-369 
 
[7] McCullagh S, Oucherlony D, Protzner A, et al. Prediction of 
 neuropsychiatric outcome following mild trauma brain injury: an 
 examination of the Glasgow Coma Scale Brain Inj 2001;15(6):489-97 
 
[8] Iverson GL, Lovell MR, Smith SS. Does brief loss of consciousness affect 
 cognitive functioning after mild head injury? Arch Clin Neuropsychol 
 2000;15(7):643-648  
 
[9] Iverson GL, Brooks BL, Collins MW, et al. Tracking neuropsychological 
 recovery following concussion in sport Brain Injury 2006;20:245-52 
 
[10] Mittl RL, Grossman RI, Hiehle JF et al. (1994) Prevalence of MR evidence 
 of diffuse axonal injury in patients with mild head injury and normal  
 head CT findings. ANJR Am J Neuroradiol 1994;15:1583-89 
 
[11] Meythaler JM, Peduzzi JD, Eleftheriou E, et al. Current concepts: diffuse 
 axonal injury–associated traumatic brain injury Arch Phys Med Rehabil 
 2001;82:1461-71 
 
  36 
[12] Schrader H, Mickeviciene D, Gleizniene, et al. Magnetic Resonance 
 Imaging after most common form of concussion. BMC Med Imaging 
 2009;17:9-11. 
 
[13] Hughes DG, Jackson A, Mason DL. et al. Abnormalities on magnetic 
 resonance imaging seen acutely following mild traumatic brain injury: 
 correlation with neuropsychological test. Neuroradiology 2004;46:550-
 58 
 
[14] Hammoud DA, Wasserman BA. Diffuse axonal injuries: pathophysiology 
 and imaging. Clin N Am 2002;12:205-16  
 
[15] Bigler ED. Neuropsychology and clinical neuroscience of persistent 
 post-concussive syndrome 2008 J Int Neuropsychol Soc 2008;14(1):1-22. 
 
[16] Lannsjö M, af Geijerstam JL, Johansson U, et al. Prevalence and 
 structure of symptoms at 3 months after mild traumatic brain injury in a 
 national cohort. Brain Injury. 2009;23(3):213-219 
 
[17] Belanger, HG, Curtiss G, Demery JA, et al. Factors moderating 
 neuropsychological outcomes following mild traumatic brain injury: a 
 meta-analysis. J Int Neuropsychol Soc 2005;11:215-27 
 
[18] Binder LM, Rowling ML, Money-matters: a meta-analytic review of the 
 effects of financial incentives on recovery after closed-head injury. Am 
 J Psychiatry 1996;153:7-10    
 
[19] Gunstad J, Suhr JA. “Expectation as eitiology” versus “the good old 
 days hypothesis”: postconcussion syndromw symptom reporting in 
 athletes, headache sufferees, and depressed individuals. J Int 
 Neuropschol Soc, 2001;7:323-33  
 
[20] Mittenburg W, DiGiulio DV, Perrin S, Bass AE. Symptoms following mild 
 head injury: expectation as aetiology J Neurol Neurosurg Psychiatry 
 1992;55:200-4 
 
[21] Belanger HG, Vanderploeg RD, Curtiss G, et al. Recent neuroimaging 
 techniques in mild traumatic brain injury. J Neuropsychiatry Clin 
 Neurosci 2007;19:5-20 
 
[22] Johansen-Berg H, Behrens TEJ. (2006). Just pretty pictures? What 
 diffusion tractography can add in clinical neuroscience. Curr Opin 
 Neurol 2006;19:379-385. 
 
[23] Taber KH, Pierpaoli C, Rose SE, et al. The future for diffusion tensor 
 imaging in neuropsychiatry. J Neuropsychiatry Clin Neurosci 
 2002;14(1):1-5. 
 
  37 
[24] Fushimi Y, Miki Y, Okada, T, et al. Fractional anisotropy and mean 
 diffusivity: comparison between 3.0-T and 1.5-T diffusion tensor imaging 
 with parallel imaging using histogram and region of interest analysis, 
 NMR in Biomedicine 2006;20:743-748. 
 
[25] Cercignani, M (2011) Strategies for patient-control comparison of 
 diffusion MR data in Jones DK, ed. Diffusion MRI: Theory, Methods and 
 Applications. New York, USA Oxford University Press, 2011:485-499 
 
[26] Jones DK, Dardis R, Ervine M, et al. Cluster analysis of diffusion tensor 
 magnetic resonance images in human head injury. Neurosurgery 
 2000;47:306-314. 
 
[27] Arfanakis K, Haughton VM, Carew JD, et al. Diffusion Tensor MR 
 imaging in diffuse axonal injury, Am J Neuroradiol 2002;23:794-802 
 
[28] Rugg-Gunn FJ, Symms MR, Barker GJ, et al. Diffusion imaging shows 
 abnormalities after blunt head trauma when conventional magnetic 
 resonance imaging is normal. Journal of Neurol Neurosurg Psychiatry 
 2001; 70,530-533 
 
[29] Levin HS, Wilde EA, Chu Z, et al. Diffusion tensor imaging in relation to 
 cognitive and functional outcome of traumatic brain injury in children. 
 J Head Trauma Rehabil 2008;23(4):197-208. 
 
[30] Lipton ML, Gulko E, Zimmerman ME, et al. Diffusion-tensor imaging 
 implicates prefrontal axonal injury in executive function impairment 
 following very mild traumatic brain injury.  Radiology 2009;252(3):816-24 
 
[31] Kumar R, Husain M, Gupta RK, et al. Serial changes in the white matter 
 diffusion tensor imaging metrics in moderate traumatic brain injury and 
 correlation with neuro-cognitive function J. Neurotrauma 2009;26:481-
 495 
 
[32] Kraus MF, Susmaras T, Caughlin BP et al. White matter integrity and 
 cognition in chronic traumatic brain injury: A diffusion tensor imaging 
 study. Brain 2007;130 (10):2508-251 
 
[33] Niogi SN, Mukherjee P, Ghajar J, et al. Extent of microstructural white 
 matter injury in postconcussive syndrome correlates with impaired 
 cognitive reaction time: a 3T diffusion tensor imaging study of mild 
 traumatic brain injury. AJNR Am J of Neuroradiol 2008 29(5):967-73.  
 
[34] Wu T, Wilde EA, Bigler ED, et al. Evaluating the Relation between 
 Memory Functioning and Cingulum Bundles in Acute Mild Traumatic 
 Brain Injury using Diffusion Tensor Imaging. J Neurotrauma 
 2009;27(2);303-7  
 
 
  38 
 
[35] Lo C, Shifteh K, Gold T, et al. Diffusion tensor imaging abnormalities in 
 patients with mild traumatic brain injury and neurocognitive 
 impairment. Journal of Computerised Assisted Tomography 
 2009;33(2):293-7 
 
[36] Little DM, Kraus MF, Joseph J, et al. Thalamic integrity underlies 
 executive dysfunction in traumatic brain injury. Neurology 2010;74:1-33  
 
[37] Christidi F, Bigler ED, McCauley SR, et al. Diffusion tensor imaging of the 
 perforant pathway zone and its relation to memory function in patients 
 with severe traumatic brain injury J Neurotrauma 2011;28(5):711-25 
 
[38] Palacios EM, Fernandez-Espejo D, Junque C, et al. Diffusion tensor 
 imaging differences relate to memory deficits in diffuse traumatic brain 
 injury BMC Neurol. 2011;23:11:24 
 
[39] Hartikainen KM, Waljas M, Isoviita T, et al. Persistent symptoms in mild to 
 moderate traumatic brain injury associated with executive dysfunction 
 J Clin Exp Neuropsychol 2010;32(7):767-74 
 
[40] Singh M, Jeong J, Hwang D, et al. Novel diffusion tensor imaging  
 methodology to detect and quantify injured regions and affected 
 brain pathways in traumatic brain injury. Magn Reson Imaging 
 2010;28(1):22-40. 
 
[41] Lipton ML, Gellella E, Lo C, et al. Multifocal white matter ultrastructural 
 abnormalities in mild traumatic brain injury with cognitive disability: a 
 voxel-wise analysis of diffusion tensor imaging. J Neurotrauma 
 2008;25(11):1335-42 
 
[42] Jones DK, Cercigiani M. Twenty-five pitfalls in the analysis of diffusion 
 MRI data. NMR Biomed 2010;23:803-820 
 
[43]     Delis DC, Kramer JH, Kaplan E et al. California Verbal Learning Test– 
    Second Edition (CVLT-II) 2000, San Antonio, TX: Psychological        
    Corporation 
 
[44]    Wechsler D. Wechsler Memory Scale. Third Edition manual. 1997 San 
    Antonio: The Psychological Corporation 
 
[45]     Wechsler D. Wechsler Adult Intelligence Scale. Third Edition manual. 
   1997 San Antonio: The Psychological Corporation 
 
[46]   Conners CK, Continuous Performance Test II. 2000, Toronto: Multi-Health 
   Systems 
 
[47]   Lezak MD. Howieson DB, Loring DW, Orientation and Attention In    
   Neuroppsychological Assessment 4th Edition, Lezak MD, Howieson DB, 
   Loring DW, eds. New York USA, Oxford University Press, 2004 
  39 
 
[48] Reese TG, Heid O, Weisskoff RM, et al.  (2003) Reduction of eddy-
 current-induced distortion in diffusion MRI using a twice-refocused spin 
 echo. Magn Reson Med. 2003;49,177-82. 
 
[49] Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring 
 diffusion in anisotropic systems by magnetic resonance imaging. 
 Magnetic Resonance in Medicine 1999;42:515-525. 
 
[50] Leemans A, Jeurissen B, Sijbers J, et al. ExploreDTI: A Graphical Toolbox 
 for Processing, Analyzing, and Visualizing Diffusion MR Data. In “Proc. 
 ISMRM 17th Annual Meeting, Honolulu, Hawaii”.2009:3536 
 
[51] Leemans A, Jones DK. The B-matrix must be rotated when motion 
 correcting diffusion tensor imaging data. Magnetic Resonance in 
 Medicine 2009;61:1336-1349. 
 
[52] Tonks J, Williams WH, Frampton I, et al. Reading emotions after 
 childhood brain injury: Case series evidence of dissociation between 
 cognitive abilities and emotional expression processing skills. Brain Inj 
 2008;22(4):325-332 
 
[53] Field A, Exploring assumptions In. Fields A, ed. Discovering statistics 
 using SPSS 3rd Ed, London UK, Sage, 2009 
 
[54] Papagno C, Miracapill C, Casarotti A, et al. What is the role of the 
 uncinate fasciculus? Surgical removal and proper name retrieval Brain 
 2011;134(2):405-14 
 
[55] Mabbot DJ, Rovet J, Noseworthy MD, et al. The relationship between 
 white matter and declaritive memory in older children and 
 adolescents Brain Res 2009;1294:80-90 
 
[56] Chun T, Filippi CG, Zimmerman RD, Ulug AM, Diffusion changesin the 
 aging human brain. Am J Neuroradiol 2000;21:1078-83 
 
[57]  Alexander AL, Deterministic White Matter Tractography in Jones DK, 
 ed. Diffusion MRI: Theory, Methods and Applications. New York, USA 
 Oxford University Press, 2011:383-395 
 
[58] Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in 
 Wallerian degeneration and their dependence on white matter 
 architecture. Neuroimage 2001;13:1174-1185 
 
[59] Behrans TE, Johansen-Berg H, Jbabdi S, et al. Probabilitic diffusion 
 tractrography with multiple fibre orientations: What can we gain? 
 Neuroimage 2007;34:144-155 
 
 
  40 
[60] Vemuri P, Weigand SD, Przybelski SA et al. Cognitive reserve and 
 Alzheimer’s disease biomarkers are independent of cognition. Brain 
 2011; 135(5):1479-1492 
 
[61] Schuff N, Zhang Y, Zhan W, et al. Patterns of altered cortical perfusion 
 and diminished subcortical integrity in posttraumatic stress disorder: an 
 MRI study. Neuroimage 2011;54(1):62-8. 
 
[62] Li C, Sun X, Zou K, et al. Voxel based Analysis of DTI in Depression Patients 
 International Journal of Magnetic Resonance Imaging 2007;1(1): 43-48 
 
[63] Moss-Morris R, Weinman J, Petrie KJ, et al. The revised illness perception 
 questionnaire (IPQ-R). Psychol Health 2002;17:1-16 
 
 
 
 
 
 
 
  41 
 
Dissemination Statement         
 
It is hoped that the findings from this work will be rewritten for submission to 
the Journal of Neurology, Neurosurgery and Psychiatry and presented at 
relevant forthcoming conferences.   
 
Given the exploratory and potentially sensitive nature of the study i.e. the 
detection of otherwise undetected brain damage, detailed feedback will not 
be presented to participants.  However, a letter providing a lay summary of 
the findings, explaining that a potentially new method of analysis of TBI using 
DTI has been explored with potentially interesting results, will be sent to TBI 
patient participants.  Those control participants who expressed an interest in 
the findings of the study will also be provided with a similar summary. 
 
The present study is considered to be exploratory and it is hoped that the 
results will form the basis of a grant proposal to permit further research in this 
area to consolidate findings.  
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APPENDIX A: NHS ETHICAL APPROVAL – SUBSTANTIAL AMMEDMENT 
 
South West 5 REC 
formerly Frenchay REC 
C/o North Bristol NHS Trust  
Beaufort House 
Southmead Hospital 
Westbury-on-Trym 
Bristol 
BS10 5NB 
 
Tel: 0117 323 5211 
Fax: 0117 323 2832 
 
25 June 2010 
 
Dr Martin Bunnage 
Consultant Clinical Neuropsychologist 
The Burden Centre 
Frenchay Hospital 
Bristol 
BS16 1JB 
 
Dear Martin 
 
Study title: Diffusion Tensor Imaging in patients with Traumatic Brain 
Injury: A pilot study of contemporary imaging methods. 
REC reference: 08/H0107/69 
Amendment number: 1 
Amendment date: 17 June 2010 
 
The above amendment was reviewed by the Sub-Committee in correspondence.  
 
Ethical opinion 
 
Favourable Opinion  
 
The members of the Committee taking part in the review gave a favourable ethical 
opinion of the amendment on the basis described in the notice of amendment form and 
supporting documentation on the basis that all data going to the student is anonymised 
ie only nature of brain injury, gender, approximate age for NHS patients. 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
 Document  Version  Date  
 Summary/Synopsis  Pilot v1  14 June 2010  
 Participant Consent Form: Student Pilot Study  1 added by 
REC  
18 June 2010  
 Participant Consent Form  3  14 June 2010  
 Participant Information Sheet: Student Pilot Study  1 added by 18 June 2010  
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REC  
 Participant Information Sheet  3  14 June 2010  
 Protocol  2  14 June 2010  
 Notice of Substantial Amendment (non-CTIMPs)  1  17 June 2010  
  
  
Membership of the Committee 
 
The members of the Committee who took part in the review are listed on the attached 
sheet. 
 
R&D approval 
 
All investigators and research collaborators in the NHS should notify the R&D office for 
the relevant NHS care organisation of this amendment and check whether it affects R&D 
approval of the research. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
08/H0107/69:     Please quote this number on all correspondence 
 
Yours sincerely 
 
 
 
 
Mr Anthony Sack 
Committee Co-ordinator 
 
E-mail: Anthony.Sack@nbt.nhs.uk 
 
 
Enclosures: List of names and professions of members who took part in the review 
 
Copy to: North Bristol NHS Trust R&D office  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 APPENDIX B: NHS ETHICAL APPROVAL - ORIGINAL 
 
 
Frenchay Research Ethics Committee 
C/o North Bristol NHS Trust  
Pembroke Room 
Beaufort House 
Southmead Hospital 
Westbury-on-Trym 
Bristol 
BS10 5NB 
 
Telephone: 0117 323 5211  
Facsimile: 0117 323 2832 
24 November 2008 
 
Dr Martin Bunnage 
Consultant Clinical Neuropsychologist 
North Bristol NHS Trust 
The Burden Centre 
Frenchay Hospital 
Bristol 
BS16 1JB 
 
 
Dear Dr Bunnage 
 
Full title of study: Diffusion Tensor Imaging in patients with Traumatic Brain 
Injury: A pilot study of contemporary imaging methods. 
REC reference number: 08/H0107/69 
 
Thank you for your letter of , responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
 
 The Committee has designated this study as exempt from site-specific assessment 
(SSA). The favourable opinion for the study applies to all sites involved in the research. 
There is no requirement for other Local Research Ethics Committees to be informed or 
SSA to be carried out at each site.  
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start 
of the study. 
 
Management permission or approval must be obtained from each host organisation prior 
to the start of the study at the site concerned. 
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Management permission at NHS sites (“R&D approval”) should be obtained from the 
relevant care organisation(s) in accordance with NHS research governance 
arrangements.  Guidance on applying for NHS permission is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date    
 Participant Consent Form  1  28 July 2008  
 Participant Information Sheet  1  01 August 2008  
 GP/Consultant Information Sheets  1  01 August 2008  
 Letter of invitation to participant  1  28 July 2008  
 Questionnaire: Second Screening  1  28 July 2008  
 Questionnaire: Initial Screening  1  28 July 2008  
 Letter from Sponsor    10 July 2008  
 Protocol  1  27 August 2008  
 Investigator CV       
 Application    01 August 2008  
 MRI debriefing sheet       
 Response to Request for Further Information       
 Participant Consent Form  2  08 October 2008  
 Participant Information Sheet  2  06 October 2008  
 Covering Letter       
 Response to Request for Further Information       
 Participant Consent Form  2.1  17 November 2008  
  
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National Research 
Ethics Website > After Review  
 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views 
known please use the feedback form available on the website. 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
 • Notifying substantial amendments 
 • Progress and safety reports 
 • Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light 
of changes in reporting requirements or procedures. 
 
We would also like to inform you that we consult regularly with stakeholders to improve 
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our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk. 
 
 
08/H0107/69 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
 
 
Dr Mike Shere 
Chair 
 
Email: Anthony.Sack@nbt.nhs.uk 
 
 
Enclosures: “After ethical review – guidance for researchers” SL- AR2  
 
 
Copy to: North Bristol NHS Trust 
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APPENDIX D: NHS ETHICS APPROVAL – LOCAL R&D ORIGINAL
  
APPENDIX E: ETHICS APPROVAL FROM CARDIFF UNIVERISTY 
 
>>> psychethics 7/13/2010 12:33 PM >>> 
Dear Derek, 
 
The Ethics Committee has considered the further information you provided for 
your  
staff project proposal: Investigating the relationship between diffusion tensor 
and  
cognitive function (EC.10.06.01.2487R). 
 
The project has now been approved.   
 
Please note that if any other changes are made to the above proposal then 
you must  
notify the Ethics Committee. 
 
Regards, 
Dominique Mortlock 
 
School of Psychology Research Ethics Committee 
Tower Building 
Park Place 
CARDIFF 
CF10 3AT 
 
Ffôn /Telephone: +44 (0) 29 2087 0360                            
Ffacs/Fax: +44 (0) 29 2087 4858   
 
http://www.cardiff.ac.uk/psych/research/ethics/      
 
 
 
 
Re: Ethics feedback - EC.10.06.01.2487R 
Derek Jones  
Sent: 15 July 2010 16:51 
To: psychethics [psychethics@Cardiff.ac.uk] 
Cc: Hanley, Laura 
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APPENDIX F: ETHICS APPROVAL EXETER UNIVERSITY 
 
 
 
 
 
 
To:  Laura Jane Hanley 
From: 
CC: 
Cris Burgess 
Huw Williams, Martin Bunnage 
Re:  Application 2010/009 to Ethics Committee 
DTI in TBI: A pilot study of contemporary methods 
Date:  09 November 2010  The School of Psychology Ethics Committee met on 13/10/10 and your NHS Local Research Ethics Committee application and approval were reviewed. In line with our procedures, your project is now de facto approved. 
 The agreement of the Committee is subject to your compliance with the British Psychological Society Code of Conduct and the University of Exeter procedures for data protection (http://www.ex.ac.uk/admin/academic/datapro/). In any correspondence with the Ethics Committee about this application, please quote the reference number above.  I wish you every success with your research.    Yours sincerely,     
 Cris Burgess Chair of School Ethics Committee 
         
 
  51 
 
RE: ethics approval query 
Burgess, Cris 
You replied on 12/10/2010 17:01. 
Sent: 12 October 2010 16:56 
To: Hanley, Laura 
Cc: Evans, Marilyn 
 
Hi Laura, 
 
I've had a chance to look through all your documentation now and can 
confirm that we are happy for you to carry out your proposed study. 
This approval is without conditions and applies for one year from 
today's date, thus almost coinciding with your proposed end date of 
1st October 2011. I wish you all the best with your research.  
 
I will be in touch more formally within the next week to provide you 
with an application/approval number, but in the meantime please treat 
this email as confirmation of our approval. 
 
Best regards, 
Cris (as Chair, Psychology REC). 
 
_______________________________________________________ 
Dr Cris Burgess 
Psychology, College of Life & Environmental Sciences 
University of Exeter 
 
Deputy Director Undergraduate Psychology 
Chair, Psychology Research Ethics Committee 
Academic Exams Officer and Chair, Undergraduate Board of Examiners 
_______________________________________________________   
Psychology Research Ethics Committee 
Burgess, Cris 
 
Sent: 13 October 2010 14:41 
To: Hanley, Laura 
 
Hi Laura, 
  
With respect to my emailed approval for your study yesterday, in future correspondence 
please can you use the Psychology REC reference 2010/09. 
  
Many thanks, 
Cris. 
  
_______________________________________________________ 
Dr Cris Burgess 
Psychology, College of Life & Environmental Sciences 
University of Exeter 
  
Deputy Director Undergraduate Psychology 
Chair, Psychology Research Ethics Committee 
Academic Exams Officer and Chair, Undergraduate Board of Examiners 
  
APPENDIX G: CONTROL PARTICIPANT INFORMATION SHEET 
 
 
 
Participants Information Sheet  09-11-10 (v4) 
 
 
 
Investigating the relationship between diffusion tensor imaging  
data and cognitive function 
 
 
Purpose of study 
We wish to obtain measures of cognitive function to explore their relationship with 
diffusion tensor imaging measures.  This data would form a control dataset that 
would be used to compare with other populations.  
 
Who is conducting the Study? 
The study is a result of a collaboration between Dr Martin Bunnage of the Head 
Injury Therapy Unit at Frenchay Hospital, Bristol and Professor Derek Jones of 
CUBRIC.  Laura Jane Hanley is a trainee Clinical Psychologist from the University of 
Exeter and will be conducting the research as part of her doctorate training.  She is 
supervised by Dr Bunnage and advised by Professor Jones 
 
Why have I been chosen? 
You have been contacted because you have already provided brain images to 
the CUBRIC control database and at this time provided consent to be invited to 
further studies at CUBRIC.  We would like you to contribute to the current study by 
completing a battery of neuropsychological tests. We would then like to compare 
the data obtained from these tests to that previously obtained from your DTI scan.  
This set of data would then contribute to a control  CUBRIC dataset which would 
then be used as a control in comparison with other populations of people e.g. 
those who have had a brain injury.  This is to enable possible relationships between 
measures of white matter integrity and cognitive function to be identified. 
 
Can I take Part? 
If you are aged 18-65 and have English as your first language, we would like you to 
consider you taking part in the study. 
 
However if you have one of the following conditions or experiences then 
unfortunately you will not be able to take part in the current study at this stage:   
 
*       People who have sustained a previous brain-injury i.e. blow to the head 
associated with loss of consciousness and / or post-traumatic amnesia of at least 5 
minutes duration 
 
*       People who have been diagnosed with or have a suspected neurological 
condition including epilepsy 
 
*       People who have had a neuropsychological assessment in the last 2 
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years 
 
*       People who have current or a history of moderate-severe mental health 
difficulties 
 
*       People with current or a history of alcohol/substance abuse 
 
*       People with current or a history of problems with aggression and anger 
control 
 
At the beginning of the cognitive testing you will be asked to confirm that you do 
not have any of these conditions or experiences.  
 
Do I have to take part? 
No.  Your participation in the study is completely voluntary.  If you do agree to take 
part and then change your mind, you can withdraw from the study at any time. 
 
What will happen if I do take part? 
You will be contacted by a researcher from the study and a time will be arranged 
for you to take part in the neuropsychological testing.  The testing will take place 
at Cardiff University at a time convenient for you.  The testing will usually take 
around 2 hours and will include a number of commonly used neuropsychological  
measures of for example, memory, reasoning, planning, organisation and problem 
solving skills.  
 
You will also be asked to provide simple demographic information that will be used 
in the analysis of the study.  This will include your age, gender, highest level of 
education, handedness (determined by the completion of a brief questionnaire), 
socioeconomic status and whether you are colour blind/wear glasses.  You will 
also be asked if you have experienced concussion in the past. 
 
All data obtained from your participation will be kept confidentially and will be 
identified by a study number rather than your name.  Steps will be taken to ensure 
that you will not be able to be identified from the publication of any findings using 
this data. 
 
If you wish to ask further details about the study please contact Laura Jane Hanley 
on ljh219@exeter.ac.uk 
 
Possible Disadvantages 
There are no harmful effects of testing except for the possibility of some mental 
fatigue. Some find the tests enjoyable and others may find them a little frustrating.   
 
Can I find out the test results? 
The results of the cognitive testing, which are a series of numbers, will not be 
routinely provided.  However you are welcome to request a full debrief of the test 
results and if after this debrief you have any further questions, access to the 
Consultant Clinical Neuropsychologist can be arranged. 
 
What if there is a problem? 
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In the unlikely event that the neuropsychological test results appear to indicate 
something potentially out of the ordinary, the results will be discussed with the 
Consultant Clinical Neuropsychologist involved in the study for a professional 
opinion.  If further action is advisable you will be contacted, the results discussed 
with you and you will be advised to contact your GP.  A letter will also be sent to 
your GP advising them of the results, their potential implication and the Consultant 
Clinical Neuropsychologist’s recommendations.  
 
 
If you wish to make a complaint about the way you have been treated in the 
study, or the way in which it was contacted conducted, you should in the first 
instance contact: 
 
Dr Martin Bunnage, Consultant Clinical Neuropsychologist 
Telephone: 0117 340 6522 
Email martin.bunnage@nbt.nhs.uk  
Post: Dr Martin Bunnage, Consultant Clinical Neuropsychologist, The Head Injury 
Therapy Unit, Frenchay Hospital, Bristol, BS16 1JB 
 
You may also contact: 
 
Professor Derek Jones 
Telephone: +44 (0)29  2087 9412 
Email: jonesd27@CARDIFF.AC.UK 
Post: Professor Derek Jones CUBRIC, School of Psychology, Cardiff University, Park 
Place, Cardiff, CF10 3AT 
 
 
Ethical Approval 
 
The study has been approved by the School of Psychology’s Ethics Committee at 
Cardiff University  
 
What do I do if I want to take part? 
 
If you would like to take part in the study, please contact Laura Jane Hanley on 
ljh219@exeter.ac.uk or at the Head Injury Therapy Unit on 01179186522 
 
Thank you for your time, 
 
 
 
 
Dr Laura Jane Hanley Supervised by Dr Martin Bunnage 
Trainee Clinical Psychologist   Consultant ClinicalNeuropsychologist 
 
      Professor Derek Jones 
      Director of MRI, CUBRIC  
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APPENDIX H: CONTROL PARTICIPANT CONSENT FORM 
 
 
Investigating the relationship between diffusion tensor imaging  
data and cognitive function 
 
 
 
 
Consent Form 
 
 
 
1. I confirm that I have read and understood the information sheet dated 09-11-
10 for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason. 
 
3. I agree that results from the neuropsychological tests and demographic 
information will be used confidentially together with measures obtained from 
the DTI scan data I previously contributed to the CUBRIC control database and 
that the data will form a control dataset that will be used for comparison with 
other populations of people 
 
4. I understand that results of neuropsychological test results will not be routinely 
be provided. However I understand that I can request a full debrief if I have 
questions about my performance and have access to the Consultant Clinical 
Neuropsychologist if questions still remain. 
 
5. I agree that, in the unlikely event that findings of the cognitive testing indicate 
something potentially out of the ordinary the results will be discussed with a 
professional psychologist in order to obtain an opinion. If appropriate, I understand 
that I will be contacted to discuss the results, and advised to contact my GP. I 
agree that a letter will be sent to my GP with the results and the recommendations 
of the Consultant Clinical Neuropsychologist. 
 
6. I agree to take part in the above study 
 
 
__________________     ________________ _______________________ 
Name of Participant  Date   Signature 
 
 
 
__________________     ________________ _______________________ 
Name of person taking Date             Signature 
Consent 
 
One copy to the participant, one copy to the researcher 
 APPENDIX I: CONTROL PARTICIPANT DEBRIEF SHEET 
  
  
  
 Debrief for Study 09-11-10 (v1) 
  
 Investigating the Relationship between diffusion tensor imaging  
 data and cognitive function 
  
  
Thank you very much for taking parting the above study.  
  
The study is a result of a collaboration between Professor Derek Jones of 
Cardiff University Brain Imaging Centre and Dr Martin Bunnage of the Head 
Injury Therapy Unit, North Bristol NHS Trust, and was conducted by Dr Laura 
Jane Hanley, a trainee Clinical Psychologist from Exeter University.  The 
research is contributing to Dr Hanley’s Doctorate in Clinical Psychology. 
 
The study seeks to explore potential relationships between diffusion tensor 
imaging measures and those of cognitive function. Today you completed a 
number of tests that measures your cognitive skills such as visual and verbal 
memory, attention, problem solving, planning and organisation. We will 
compare the measures obtained from these cognitive tests (which are a 
series of numbers), with those derived from the Diffusion Tensor Imaging scan 
you previously contributed to the CUBRIC database, to explore whether there 
are any relationships between cognitive measures and DTI measures in white 
matter areas of the brain.  This data wil form a control dataset that will be 
used in comparison with data from other populations of interest. 
 
The cognitive testing data will be kept confidentially and will the cognitive 
data will not be stored with your name, only a study identification number.  
You can decide to withdraw from the study ay any time. 
 
If you have further questions please contact the researcher: 
 
Dr Laura Jane Hanley 
ljh219@exeter.ac.uk, 01179186522 
 
Supervised by:  
Dr Martin Bunnage, Head Injury Therapy Unit, Frenchay Hospital, Bristol 
Martin.Bunnage@nbt.nhs.uk, 01179186522 
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Professor Derek Jones, CUBRIC, Cardiff 
Jonesd27@cardiff.ac.uk, 02920 879412 
 
If you wish to make a complaint you may do so by Dr Bunnage or Professor 
Jones or the Psychology Ethics Committee Secretary at:  
 
Email: psychethics@cf.ac.uk 
Phone: +44 (0)29 208 74007 
Fax: +44 (0)29 2087 4858 
Post: Psychology Ethics Committee Secretary 
Cardiff University Tower Building Park Place Cardiff CF10 3AT 
 APPENDIX J: PATIENT PARTICIPANT CONFORM FORM 
 
 
THE BURDEN CENTRE for 
Neuropsychiatry, Neuropsychology and Epileptology 
Frenchay Hospital,  
Bristol  BS16 1JB     
Department of Neuropsychology 
        Tel. 0117 340 2235 (Child) 
                         0117 340 2290(Adult) 
 
Consent Form 
 
Diffusion Tensor Imaging in Traumatic Brain 
Injury 
 
Version 3.0 
Date 14/06/2010 
Martin Bunnage 
Simon Gerhand  
Emma Hale  
Helen Miller  
Margaret Newson   
Helen Thorburn  
Ingram Wright HoD 
 
 
 
 7. I  confirm  that  I  have  read  and  understood  the  information  sheet  dated  06/10/2008 Version 2.0 for the above study. I have had the opportunity to consider the information, ask questions and have had these answered satisfactorily. 8. I understand  that my participation  is voluntary and  that  I  am  free  to withdraw at any time without giving any reason, without my medical care or legal rights being affected. 9. I understand  that  relevant  sections of my medical notes and data  collected during  the study, may be looked at by individuals from CUBRIC, from regulatory authorities or from the NHS Trust, where it is relevant to my taking part in this research. I give permission for these individuals to have access to my records. 10. I agree to provide my contact details so that the researchers can organize my trip to the scanner  in  Cardiff  and my  GP  and  Consultant’s  details  should  the  researcher  need  to inform them of any relevant findings from the scan. 11. I agree to my GP being informed of my participation in the study.  12. I  agree  that,  in  the  unlikely  event  that  some  abnormality  is  discovered  on  the  scan, Cardiff University staff can show the scan to qualified medical professionals in order to obtain a medical opinion. If appropriate, I agree that my GP and treating Consultant (if I have one) can be contacted in writing with the results of the MRI scan. 
13. I agree that results of neuropsychological tests I have already completed at HITU 
can be used anonymously in the analysis of the study 14. I agree to take part in the above study    __________________      ________________  _______________________ 
Name of Participant    Date      Signature 
 
 __________________      ________________  _______________________ 
Name of person taking    Date      Signature 
Consent 
 One copy to the participant,  One copy to the researcher,  One copy to the medical notes 
  59 
My Contact Details   
 
Address:_________________________________________________________________ 
 
 
 
Telephone number: _________________   
My GP’s Details   
 
Address:_________________________________________________________________ 
 
 
 
Telephone number: _________________ 
 
 
My Consultant’s Details   
 
Address:_________________________________________________________________ 
 
 
 
Telephone number: _________________    
 APPENDIX K: PATIENT INFORMATION SHEET 
 
 
THE BURDEN CENTRE for 
Neuropsychiatry, Neuropsychology and Epileptology 
Frenchay Hospital,  
Bristol  BS16 1JB    
 
Department of Neuropsychology 
        Tel. 0117 340 2235 (Child) 
                        0117 340 
2290(Adult)      
 
Patient Information Sheet 
 
Diffusion Tensor Imaging in Traumatic Brain 
Injury 
 
Version 3.0 14/06/2010 
Martin Bunnage 
Simon Gerhand  
Emma Hale  
Helen Miller  
Margaret Newson   
Helen Thorburn  
Ingram Wright HoD 
 
 
 
 
Dr Martin Bunnage, Consultant Clinical Neuropsychologist,  
Clinical Lead of the Head Injury Therapy Unit, Department of Neuropsychology, Frenchay 
Hospital 
 
Professor Derek Jones, Director of MRI, CUBRIC, Cardiff University 
 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take the 
time to read the following information carefully. Talk to others about the research if you wish. 
Feel free to ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. You ongoing treatment from the 
Head Injury Therapy Unit  will in no way be affected by whatever decision you choose to 
make. 
 
 
Part 1 
 
Purpose of the Research 
Traumatic Brain Injury (TBI) results in brain damage. The more severe the injury, usually the 
more severe the damage. More severe damage is usually associated with greater problems 
with daily living, i.e. problems with thinking skills, emotions, and physical function. 
Traditional Magnetic Resonance brain Imaging (MRI) does not capture very well the damage 
caused to the connections between brain cells and between different brain regions that can 
happen following traumatic brain injury. Diffusion Tensor Imaging (DTI) is a recent 
development within the field of MRI which is exquisitely sensitive to the types of changes 
that can happen following traumatic brain imaging. This information, it is hoped, will be 
useful in making more reliable predictions about the outcome from TBI.  
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Why have I been invited? 
You have been invited because you have sustained a traumatic brain injury. If you choose to 
participate you will be one of approximately ten people who will be scanned using the state-
of-the-art brain imaging facilities at Cardiff University. 
 
Do I have to Take Part? 
Simply put, NO, you do not have to take part. This is a research trial and is not part of your 
ongoing treatment from the Head Injury Therapy Unit. It is up to you to decide. We will 
describe the study and go through this information sheet, which we will then give to you. We 
will then ask you to sign a consent form to show you have agreed to take part. You are free to 
withdraw at any time, without giving a reason. 
 
What will happen if I take part? 
If you agree to take part in this research study you will need to travel to CUBRIC which is 
part of Cardiff University, in Cardiff. You will only need to attend this facility once and you 
will need to be there for about two hours, with approximately 50 minutes of your time being 
spent within the MRI scanning machine itself. 
 
The precise day and time for the scan will be decided at some future point. This will be a day 
that is mutually convenient for both you and for CUBRIC. Scans will only happen on 
weekdays and only during normal working hours, i.e. 9am – 5pm. 
 
This scan is not part of routine clinical care and as such is over and above that which you 
would normally be asked to do as part of your care. 
 
Once you arrive at CUBRIC you will be met by Dr Martin Bunnage and Professor Derek 
Jones. We will talk you through the procedures for the day and you will be asked to complete 
some questionnaires that relate to safety and MRI. The procedures for the brain scan will be 
explained to you and you will have the opportunity to ask any questions you may have. You 
will then be asked to consent to having the scan done. 
 
For the scan itself you will be asked to lie in on your back inside the (MRI) scanner tube 
while images are acquired. The scanner can be noisy while acquiring images and so we will 
give you earplugs to wear and there will be additional padding placed against your ears.  A 
pulse-oximeter (a device that looks a bit like a clothes-peg) will be placed on the finger to 
synchronize the acquisition of the images to your heart beat. You will be given a bulb to 
squeeze which will alert the operator to pause / stop the scan. There is an intercom fitted so 
that you and the operator can talk with each other.  You need only stay as still as possible 
during. You will not be required to wear a special gown, but rather will need only to ensure 
that there are no large metal parts on your clothing. You can, if you want to, watch a subtitled 
movie while in the scanner.  It is possible to have the scanning broken up in to separate 
chunks if you are unable to stay still for that long. All scans are completely non-invasive and 
do not employ ionizing radiation.  
 
It may be that you are at CUBRIC at lunchtime, if this is the case money for lunch will be 
provided. 
 
Once you have been scanned you will attend a de−briefing with Dr Martin Bunnage and the 
Head of Structural Imagining at the centre, Professor Derek Jones. Once you have been de-
briefed and had the chance to ask any questions you may have you will be free to return to 
Bristol.  
 
We would also like to use the results of the neuropsychological tests (e.g. tests of memory, 
attention and problem solving skills) that you will have completed at HITU.  This is so that 
we can investigate whether the findings from the scan taken at CUBRIC are related to 
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thinking skills and mood.   You will not need to take any more tests than the ones that you 
will have already completed as part of your routine treatment at HITU. 
 
Expenses and Payments 
We aim to ensure that nobody is ‘out of pocket’ by taking part in this research project. This 
means we will pay for your travel to and from CUBRIC and will pay for lunch if you are at 
CUBRIC over lunch. We will also pay for any other reasonable costs associated with your 
involvement with the research. Money will be reimbursed either on the day of you scan or 
later by post. You will need to bring a receipt for your expenses to allow us to reimburse you. 
 
What will I have to do? 
You will need to travel to CUBRIC in Cardiff and spend about two hours at the centre. While 
at the centre you will need to complete some paperwork and then undergo an MRI brain scan. 
This will involve spending about 50 minutes in the MRI machine keeping as still as you can. 
 
You will need to provide Dr Martin Bunnage with your contact details and the contact details 
of your GP. We need this information in order to organise the scans and so that we can tell 
your GP of your involvement with the study. 
 
What are the possible disadvatages and risks of taking part? 
There is a small risk of anxiety and feelings of panic associated with being in the scanner, a 
risk that staff at the centre are very familiar with. If at any time you feel uncomfortable you 
are free to stop the scan and if you wish withdraw from the study. 
 
There is a small risk that the MRI scan may identify a new medical issue, not already known 
to you and your doctor. Some such 'discoveries' have the potential to impact upon an 
individual's ability to obtain life insurance, for example if a brain tumour were identified. You 
need to consider this before agreeing to take part in the study 
 
The study may require up to a day of your time, i.e. to get to Cardiff, to have the scan, to be 
de-briefed and then to return to Bristol. This schedule is potentially very tiring. In addition, 
for those of you with orthopaedic and physical injuries there is the potential for pain and 
discomfort associated with the travelling and being in the scanner. You need to consider 
whether you are able to cope with this potential discomfort prior to agreeing to take part in the 
study. 
 
What are the side effects of the DTI scan 
None known 
 
What are the possible benefits of taking part? 
This study will not help you particularly but it is hoped that the information we gather from 
this research will help us to better understand the kind of damage that can occur to the brain 
following traumatic brain injury. 
  
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed. Please see Part 2. 
 
Will my taking part in the study be kept confidential? 
Yes. We will; follow ethical and legal practice and all information about you will be handled 
in confidence. Please see Part 2. 
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Part 2 
 
 
What if relevant new information becomes available? 
Sometimes we get new information about the methods used in this research. If this happens 
Dr Martin Bunnage will contact you and discuss with you what this knew iformation means in 
relation to your continued participation in the study. If you decide not to carry on with the 
research Dr Bunnage will make arrangements to remove you from the study and will ensure 
this does not impact upon the care you receive from the Head Injury Therapy Unit.  
 
What will happen if I don’t want to carry on with the study? 
You are free to withdrawal from the study at any time. If you do decide you no longer want to 
be involved with the research. We will keep your MRI data in an anonymous form for use in 
the analysis part of the study unless you ask us to destroy. If you ask us to we will destroy all 
of the data we have collected from your participation in the study.  
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to Dr Martin 
Bunnage who will do his best to help answer your question. He is contactable in the following 
ways. 
 
Telephone: 0117 340 2290 
Email martin.bunnage@nbt.nhs.uk  
Post Dr Martin Bunnage, Consultant Clinical Neuropsychologist, The Burden Centre, 
Frenchay Hospital, Bristol, BS16 1JB 
 
If you remain unhappy and wish to make a formal complaint you can do this through the NHS 
Complaints Procedure. Details can be obtained from the hospital on Tel 0117 9701212 
 
In the event that something does go wrong and you are harmed during the research and this is 
due to someone’s negligence then you may have grounds for a legal action for compensation 
against North Bristol NHS Trust but you may have to pay your legal costs. The normal 
National Health Service complaints mechanisms will still be available to you. 
 
Will my taking part in this study be kept confidential? 
Personal addresses, postcodes and telephone numbers will be used in communicating research 
arrangements with you. 
 
A record will be kept securely on Frenchay Hospital’s computer system of each volunteer in 
the study and will be accessible to Dr Martin Bunnage. You will each be allocated a “study 
number” which will be used to identify you, rather than using your actual name. This helps to 
keep your personal information safe.  
 
The outcome of the MRI analysis undertaken by CUBRIC will be transferred electronically 
between Professor Jones and Dr Bunnage in an anonymous form so that you can not be 
identified from the information transferred. 
 
Draft manuscripts pertaining to the publication of the data derived from this study will be 
electronically transferred between Dr Bunnage and Professor Jones. These manuscripts will 
not contain any personal identifying information. 
 
The actual imaging data will be pseudo-anonymised and include a study date, and stored 
securely on the password protected University computer network at CUBRIC. Any data that 
leaves CUBRIC will be fully anonymised. 
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The imaging data analysis will take place at CUBRIC and will be undertaken by Professor 
Derek Jones. 
 
The overall study analysis will take place both at CUBRIC and at Frenchay Hospital by both 
Professor Derek Jones and by Dr Martin Bunnage. 
 
Your data may be stored for use in future research. It may be stored for up to 10 years. If any 
future use is intended for your stored data an application to Frenchay Research Ethics 
Committee will be made to ensure this data is handled in an appropriate way. If you do not 
wish for us to store your data please inform us in writing at any time and we will 
delete/destroy all your data. 
 
Involvement of the General Practitioner / Family Doctor (GP) 
We intend to inform your GP if you agree to take part in this study. We will only be telling 
your GP that you are enrolled in the study. We will not be routinely sharing any information 
obtained from your scan. If, however, an unexpected abnormality is found on your scan we 
will inform your GP so that they can make appropriate follow up arrangements.  
 
What will happen to the results of the research study? 
It is intended that the outcome of this research is published either in a scientific journal or 
presented at a conference. The results will be anonymised and it will not be possible for 
anyone to be identified from these published results. If you are interested a copy of this 
published work can be obtained from Dr Martin Bunnage upon request.  
 
Who is organising and funding the research? 
This research is being funded by Professor Derek Jones from his funds at Cadiff University. 
Dr Martin Bunnage is not being paid to be involved in this research 
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee to protect safety, rights, wellbeing and dignity. This study has been 
reviewed and given favourable opinion by Frenchay Research Ethics Committee. 
 
 
Yours sincerely 
 
 
Dr Martin Bunnage BSc(Hon) M.Psych (Neuro) PhD C.Psychol 
Consultant Clinical Neuropsychologist  
Honorary Lecturer University of Bristol 
  
APPENDIX L: PATIENT PARTICIPANT DEBRIEF SHEET 
 
 
MRI Debriefing Sheet 
 
Study title Diffusion Tensor Imaging in Traumatic Brain Injury 
 
Thanks Many thanks for taking part in this study. We hope it was interesting. Please feel free to ask the Researcher any questions you have about what happened.  Please  note  that  some  of  the  information  contained  on  this  form  is  a  repeat  of  what might be found on the Volunteer Information Sheet, which you should already have and can keep. 
 
What was the purpose of the study? We  are  a  group  of  scientists  performing  research  using  a  medical  imaging  technique called magnetic  resonance  imaging  (MRI). Our work  involves developing new ways of using MRI    to  take pictures of  the brain. We hope  the methods we are developing will lead to new techniques to be used in medical diagnosis as well as research studies.   
What happens if you find something on the scan? Very  occasionally, when we  look  at MRI  data,  unexpected  potential  abnormalities  are discovered. We  are  not medical  practitioners  but  once we  have  looked  at  the  data  in some detail, we may ask a Medical Consultant to examine the data, and if appropriate a report  can  be  forwarded  to  your  GP  and  treating  consultant  if  you  have  one.  The researchers involved do not have expertise in medical diagnosis, as they are not medical doctors. You should not regard this research scan as a medical screening procedure.   
Are the procedure and results confidential? All  information which  is collected about you during  the course of  this research will be kept  strictly  confidential. We may  share  the data we  collect with  researchers  at  other institutions, for example with the researchers at Frenchay Hospital, but any information which leaves the Cardiff University Brain Repair and Imaging Centre MRI suite will have your name and address removed so you cannot be recognised from it. Any information about  your  identity  obtained  from  this  research  will  be  kept  private.  In  any  sort  of report we might publish we will not  include  information  that will make  it possible  for other people to know your name or identify you in any way.  
What will happen to the results of the research study? Where appropriate, the results of this study will be presented at medical and scientific conferences  and  published  in  journals.  You  will  not  be  identified  in  any  report  or publication. The results of this study will also help us to design future research projects, and possibly lead to new methods of diagnosis for neurological conditions. 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What do I do if I am unhappy with the way I was treated or with something that 
happened to me? 
 In  the  first  instance,  you  should  contact  Mrs  Lisa  Kennedy;  Email: KennedyLC@cardiff.ac.uk   Tel: +44 (0)29 2087 6912. 
 
Who has reviewed the study? This  study  has  been  reviewed  and  approved  by  the  Frenchay  Research  Ethics Committee.  
Contact for Further Information  Prof. Derek Jones, telephone 029 2087 9412, or e‐mail jonesd27@cardiff.ac.uk  Dr Martin Bunnage, telephone 0117 340 2290, or e‐mail martin.bunnage@nbt.nhs.uk  
 
 APPENDIX M: INCLUSION AND EXCLUSION CRITERIA FOR PATIENT  
   POPULATION – FROM NHS ETHICS FORM 
 
 
INCLUSION CRITERIA 
 
1. Suffered a traumatic brain injury, i.e. blow to the head associated with loss of 
consciousness and / or post traumatic amnesia of at least 5 minutes duration. This is 
necessary to ensure that the study examines appropriate cases.  
 
2. Suffered a traumatic brain injury between 12 months and 24 months ago. This time 
frame is optimum time to 'see' the full damage associated with a traumatic brain 
injury. Too soon and one would not see all the damage that takes time to evolve and 
too late and the picture may be confounded by other factors that can potentially 
influence the appearance of the brain, e.g. chronic alcohol misuse or the chronic use 
of antiepileptic medications  
 
3. Medically stable and independent in personal care. Necessary because of the 
'outpatient' nature of the study and because CUBRIC is not set up for the study of 
patients and does not have medical staff at hand in case of medical emergency.  
 
 
EXCLUSION CRITERIA 
 
1. History of other neurological disease/disorder because these, by virtue of their 
ability to effect brain  
structure and function, have the potential to significantly confound the results of a 
study attempting to quantify the effects of TBI on brain integrity.  
 
2. History of chronic alcohol/substance misuse because this, by virtue of its ability to 
effect brain structure and function, has the potential to significantly confound the 
results of a study attempting to quantify the effects of TBI on brain integrity.  
 
4. History of mental illness because this, by virtue of the possibility it reflects abnormal 
brain development / function, has the potential to significantly confound the results 
of a study attempting to quantify the effects of TBI on brain integrity.  
 
5. Current alcohol/substance misuse because this will likely impact negatively upon 
the level of cooperation and reliability of a participant as well as potentially exposing 
the research staff and other participants to unnecessary risks.  
 
6. Current severe mental illness because this will likely impact negatively upon the 
level of cooperation and reliability of a participant as well as potentially exposing the 
research staff and other participants to  
unnecessary risks.  
 
7. A diagnosis of epilepsy because this exposes the research staff to an avoidable 
potential medical risk.  
 
8. A history or current problems with aggression and anger control as this exposes the 
research staff and participants to an unnecessary risk.  
 
9. The CUBRIC screening requirements in relation to contraindications to undergoing 
MRI will also be applied e.g. metal implants 
 
10. Inability to provide informed consent.  
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APPENDIX N: BRIEF SUMMARY OF KEY FACTORS IN RESEARCH STRATEGY  
Recruitment of participants 
 
Sample size of possible control participants: 31 
Number of control participants eligible to take part: 24 
Number of control participants invited: 24 
Number of control participants consented to take part: 12 
Number of control participants tested: 11 (1 did not meet exclusion criteria) 
 
Sample size of possible clinical participants: approx 60 per year 
Number of control participants eligible to take part: approx 12 
Number of clinical participants invited: approx 8 
Number of clinical participants consented: 4 
Number of clinical participants scanned: 4 
 
 
Timeline of Data Collection and analysis 
 
July 2010 – Cardiff ethics approval granted 
 
August 2010 – NHS ethics approval complete 
 
October 2010 – Exeter ethics approval granted 
 
November 2010  - taught how to use software to analyse DTI scans 
 
December 2010 – February 2011: Technical problem with software preventing transfer 
and analysis of all DTI scans already acquired (13/15 participants) 
 
March 2011 – Continuing software problems preventing analysis as before 
 
mid March 2011 – Participant recruitment complete for control neuropsychological 
testing and patient DTI scans  
 
end March 2011- Identified differences in data acquisition that took place in preliminary 
study before present study. Consequently all anaylsis completed up to this date required 
reprocessing 
 
mid April 2011 - Reprocessing of scans to ensure consistency (completed by Prof Jones) 
 
April 2011 – Request for extension approved 
 
May 2011 – Analysis of reprocessed and new scans to be complete 
 
June 2011 - draft to supervisors 
 
July 2011 – submission   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APPENDIX O: BRIEF SUMMARY OF SKILLS LEARNT FOR RESEARCH PROJECT   
• Basic use of  LINEX/UNIX software programs inc MATLAB 
• Understanding of basic principles of Diffusion Tensor Imaging (1 full day + 1.5 hour 
workshop attended)  
• Training in DTI analysis using deterministic tractography 
• Use of Neuropsychological tests in research setting 
 
